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In allergic col■Jun tivitis,the carly phase reaction has been studied cxtensivcly both in humans and
animals.Although cellular iniltration is the lnain feature of thc late phase reaction,the rOle Of cellular
inllnunity remains unclear The purpOse ofthis study,vas to elucidate the rOlc Of cellular ilnmunity both
in the induction and effcctOr phases of cxperilncntal allcrgic blcpharocOttunctiVitis(EAC).To analyse the
involvement ofcellular irnmunity in the inductiOn phasc,6-8-wcck―old male Lewis rats werc inlmunizcd
with ovalbumin(OVA)cmulSincd with complcte Freund's adJuvant(CFA),incOmplete Frcund's attuVant
(IFA),TitcrMaxR(TM),aluminum hydrOxide[Al(OH)3]'°r WithOut any adJuvant.Thrcc weeks after
ilnmunization,the rats M″erc challenged wvith Ov´i by eye drops,and 24 hr later thcyャvere cuthanized
and their eyes,including the lids,b100d,and lymph nOdes wvere harvested for analysis Of disease and
immune rcsponses.The rcsults indicated that attuvantS Were necessary to inducc disease as vvell as bOth
cellular and humoralilllmunity Al(OH)3'CFA and TM induced stronger disease and cellular irnmunity
than IFA.The intensity of disease corrclated wvith that Of cellular immunity To furthcr investigate the
involvement of ccllular inllnunity in EAC, lymph nodc cells collected fronl inllnunizcd rats wcre
adoptivcly transfcrred into naive syngcneic rccipients that wcre challcnged 4 days latcr vvith OVA.EAC
devc10ped in the rccipients of lymph nOdc cells that werc also stimulatcd in culture M″ith OVA.Thcse
rccipient rats dcvelopcd cellular iniltration in the lid and cOlliunctiVa,in a dose―dcpendent manner.
These results suggest that cellular imn■unity played  rnaior role in thc deve10pment of EAC,both in the
induction and effectOr phases.                                ◎ 1 99 7 Acadenlic Press Limited
K`y l17ο〃si allergy;cottunctiVitis;attuvant;adOptive transfer;cellular in■munity;r ts;EAC.
1. IntroductiOn
Allergic cOniunct市itiS is one of the mOst common
ocular patho10gical conditions evaluated in eye clinics.
Chief cOmplaints of patients include itching and
burning, and their clinical signs are chemosis, con―
junctival hyperelllia and lid swvelling (Tuft et al.,
1991).Studies Of experimental animal mOdels which
c10sely resemble human allergic cOttunctiVitis indi―
cated that lgE mediated type l allergy is mainly
involved in the induction Of this fOrm Of the disease
(Donshik,1988;Doherty,1989;Anderson,1992).
During the deve10pment of allergy, tvvo phases,
namely,early phase reaction and late phase reaction
are observed(Gleich, 1982).Early phase reaction is
due tO upregulatiOn Of vascular permeability caused
by agents such as histalllines(Kitamura, 1989),and
late phase reaction is induced by chemoattractant
factor―dependent  cellular  inlltratiOn  (Zweillnan,
1993). Early phase reaction in allergy has been
studied extensively and therapeutic approaches tar―
geted for it, such as tOpical vasOcOnstrictor/
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antihistanline agents, are being used in clinics
(Norman,1993).
In the initiation of illnrnune responses in experi―
mental anirnals,attuvant  have been used to augment
either cellular inlinunity,humoralirnmunity,or both
(COligan et al.,1992;Paul,1993).IInlnunization vvith
a protein in the absence of adiuVants can elicit a much
vveaker Or dilnin shed irnmunity. It is generally
thought tha  adiuVants such as CFA tend to prOmOte
higher Thl cellinductiOn than Th2,wvhereas those as
IFA tend to promote higher Th2 cell induction
(Germann et al.,1995;ルIauri et al.,1996;Trinchieri,
1995).TherefOre,it may be possible to manipulate the
il llmune status us ng a particular adiuVant.
Recently,the rnechanislfl1 0f Cellular iniltration has
been studied particularly with regard tO asthma and
the essential role Of T_cclls in chronic asthma vvas
suggested by J.G.ルIa tin and his cowOrkers(OhVen_
stein et al.,1993;WVatanabe et al.,1995).ThiS grOup
reported that adOptive transfer of antigen prirned CD4
pOs tive T―cells cOuld induce allergic airvvay responses
and nalyzed the detailed lllechanisms oftheir roles in
late phase reaction・
Ba ed on this information,wve investigated the role
off ur adiuVants in cellular ilnmune responses in EAC
and vvhether EAC could be transferred into naive
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recipients by adoptive transfer of immune cells. WVe
also tested the efrects of stimulation in vitro on
adoptive transfer of both disease and illllllllunity.
2. ⅣIaterials and LIethods
Rαts
Six― to eight―wveek―old lnale Lewis rats vvere pur―
chased from a commercial source(SeaC Yoshitomi,
Fukuoka,Japan)and maintained in a specinc patho―
gen―free anilnal facility at Kochi ⅣIedical School.All
anilllal procedures conformed tO Institutional Cuide―
lines and the ARVO ResolutiOn on Use of Animals in
Research.
Illl“Inizα
`Iθ
ll
Rats wereinieCted with 100 μg ofovalbumin(OVA,
grade V, Sigma IIInmunochelnicals, St. Louis, 1710,
U.S.A.),with Or without adiuVant,in a nnalv。lume of
100 μlin their left hind foot―pad.The adiuVants used
were:CFA(Yatoron,Tokyo,Japan),IFA,TⅣI(CytRx
Co.,Atlanta,GA)(Roberge et al.,1992)and Al(OH)3
(200 mg/ml)・
Eκ′ιrimι71ιαI Prθιθθl                _
(1)Optimization of experimental conditions:CFA
or TM was chosen for the adiuvantin this experiment.
To ■nd out the best tirne for challenge, the rats
received eye drops in both coniunctiVal sacs with
250/rg of OVA in 50 μl phosphate―buffered saline
(PBS)at 7, 14, 21 or 28 days after illnllnunization.
Tvventy four hours later, they were clinically ex―
anlined.Then,they vvere killed by diethylether and the
eyes including lids, blood and lymph nodes wvere
harvested for histology, antibody titer by enzyme―
linked ilnrnunosorbent assay(ELISA)and lymphocyte
proliferation assay,respectively.The detailed methods
are described belowv. To observe the clinical changes
after challenge, OVA―prilned rats were exanlined
clinically at 6,24 or 48 hr after challenge.
(2)Analysis of elfects of the ibur adiuvants On the
induction phase by active illllmunization:2 1 days after
illllmunization with or without any adiuVant, rats
wvere challenged vvith OVA as described above.Twenty
four hours later, the rats wvere killed and the same
procedures as(1)Were performed.
(3)Analysis of effector phase by passive irnmuniza―
tiOn(adOptive transfer of OVA prilned cells):cellS from
ilnrnune inguinal lymph nodes were harvested 14
days after irnmunization.The cells wvere washed threc
times with RPM1 1640 medium(Nikken Bio Medical
Laboratory, Kyoto, Japan)Supplemented vvith 100
U/ml penicillin,100 μg/mlstreptomycin and 2 mM L―
glutanline and iniected tO naive syngeneic rats directly
or follovving stimulation in culture. For the stimu―
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lat on,OVA prilllled lymph node cells(100×106)were
Cultured in 25 cII12 flaSks(Nunc,Roskilde,Denmark)
in 10 1n  RPⅣI1 1640 supplemented wvith 2 1nM L―
glutamine,5×10 M2-mercaptoethanol(2-ME),100
U/ml penicillin,100 μg/ml streptomycin,50 μg/ml
OVA and containing 10%fetal Calf serum(FCS,ICN
BlomedicalJapan CO.,Tokyo,Japan)。After incubation
for 3 days,stilllllulated lymph node cells wvere harvested,
washed th ee times,and iniected into recipient rats
intravenously (Ⅳ10C zuk  et al., 1985). Four days
follow g the cell inieCtiOn,recipients were challenged
with OVA as described above.Eyes,blood and spleens
were harvested 24 hr after challenge for histology,
ELISA,and proliferative responses,respectively.
(4)Analysis ofeffector phase by adoptive transfer of
ilnrnune serulrn: serum fronl inllnunized rats vvere
collected and pooled 2 1 days after ilnmunization.
Their antibody titers against OVA ltrere tested by
ELISA.(l ml)Was iniected intravenously into
naive rats and they wvere challenged iust after transfer.
Thc anilnals were exanlined for the development of
EAC every 6 hr unti1 24 hr after transfer at wvhich tillne
the anilnals vverc killed.
Clinicαl Crα′14g αlld C`II Cθunι14J
The follovving clinical scoring system was used.
Each eye vvas assessed for the indings of lid swvelling
and discharge,and each inding vvas scored as l point.
For example,ifthe right eye had no changes and the
left eye had both discharge and lid swelling, the
gradi  score ofthis rat wvas 2 points.Ocular changes
were also ex mined istological157.Atter clinical
evaluation,eyes,including the lids,were ixed in 10%
buffered formal n and embedded in paramn.sections
(10 μm)Were Cut and stained with hematoxylin―eosin.
The iniltrated cells wer  counted in the palpebral
COniunctiva using an eye piece grid at 400×
magnincation.
ASSιS771ιηιげ CιIIレαr lllllllun`RιΨθns`s
ln each experirnent,cither lymph nodes or spleens
from two rats wvere combined per group and experi―
ments vvere repeated as recorded. Lymph node cells
wvere used for experilnents of active illllmunization,and
splenocytes for thosc of passive illllllnuniZation.Lylrn―
phocyte proliferation assays lvere set up in quadrupli―
cate in 96-wvell lat bottoln plates.Either lymph node
cells or splenocytes(3×105 cellS/well)Were Cultured
in a flnal volu e of O・2 1nl RPⅣI1 1640 medium
supplemented with 5%FCS,2-ME(5×105M),L―
glutamine(2 mM),penicillin(100U/ml)and Strep―
tomycin(100 μg/ml)・CellS Were stimulated with OVA
at anal concentrations of O・1,1,10,100 μg/nll.A ter
incubation for 72 hr at 37°C in a hunlidined at_
mosphere with 5%C02'Cultures were pulsed for 1 6 hr
with O・5/rCi/Wel1 0f[3H]th midine oapan Atomic
Energy Research lnstitute, Tokai, Japan). Cultures
CELLULAR IM M∪NITY IN EAC
wvere then harvested and the radiOactivity vvas
measured by standard techniques. Data vvere ex―
pressed as stilnulation indices(S.I.).
Ass`ssm`4ιげH■711θrαl IIll“′n`RιΨθnsι
Serullll vvaS COllected frollll each rat via cardiac
puncture at the tillle of killingo Serulln antibody levels
against OVA were llleasured by direct ELISA.OVA
(500 ng/We11)Were absorbed t0 96-well plates for 2 hr
at 37°C.The plates wvere vvashed wvith PBS¨T veen and
serially diluted serun■sample  wvere added to the wvells.
Bound Ab ■vas detected by peroxidase―colliugated
anti…IgG or lgE(Nordic IIlllllnunological Laboratories,
Tilburg,The Netherlands).The plates were developed
using  3,3/,5,5/―tetramethylbenzidine base (TLIB―
ELISA,GIBCO BRL,Gaithersburg,ⅣID,U.S.A.)and the
optical density(OD)for eaCh Well was read at 610 nm.
3.Results
■mι―cθursιげEAC
The tilllle¨course of EAC in rats inlrllunized wvith
OVA clnulsined with cFA or TⅣIis shown in Table I.
As seen, the onset of EAC wvas at day 14 after
illlllllunization and the inianllnation continued until
day 28.The maxillnal grade was obtained at day 2 1.
These results wvere further supported by the his―
tological exallnination which shOwed cellular inil―
tration in the lid and coniunctiVa.The correlatiOn of
clinical scOre and histological indings vvas sunllna～
rized in Table II.Interestingly,even though there were
TABLE I
Dis`αθ
“
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FIG. 1.Clinical grading of EAC in OVA immunizcd rats
with two kinds of attuvantS[CFA(回)or TM(m)]at threc
diff rent tirne points after challenge.
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FIG.2.Clinical grading of EAC in OVA immunizcd rats
with four kinds of attuvants Or without any adJuvants.
Tャventy―one days after irnmunization, Lcwis rats were
challcnged vvith OV′i by eyc drops,and they wvere checkcd
and gradcd clinically 24 hr later, fo1lolving materials and
methods.
no remarkable difrerences in disease betwveen the two
groups,the proliferative responses Oflymph node cells
fl・olllrl the TⅣI group started to be Observed 7 days after
ilninunization (data not showvn)。 WVe al o tested the
kinetics of disease grade after challenge frOm 6 hr to
48 hr after eye drops. As shown in Fig. 1, cellular
inlltration began to be noticed 24 hr after challenge
and continued unti1 48 hr. FroΠl these results, wve
chose day 21 for the challenge and 24 hr after
challenge as the tilne point of killing。
CθlllparisθnげA″■7αntsf lllductiοnげEAC
The chnical grading of EAC in rats inllnunized vvith
the different adiuVants is summarized in Fig.2.The
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*The number ofrats developed EAC/the number of rats te ted
l The mean grading scOre followed by the grading system writt n
in lnaterials and methods
TABLE Ⅱ
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Clinical  lnlltrated cell numbcr
grading   (mean±s.E.)
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results show that if rats were immunized with OVA
without any adiuvant,no changes were observed.In
addition,vve noted variations in the severity of EAC
among the grOups illllmunized wvith the various
adiuVants.All rats which were immunized with
Al(OH)3 eXhibited llnaximal grading scores.The rats
ilnlnunized wvith IFA showed intermediate grades.CFA
and TM induced slightly milder diseases than Al(OH)3・
The chnical grading correlated with the histological
scores of each rat.
CοlllPαrisθnげAのレVαnts,I172“unθ RιΨθnsιs
We tested cellular irnmune responses Oflymph node
cells fl・Om OVA immunized rats with allfOur adiuvantS
to investigate the relatiOnship between illnmune
responses and the deve10pment of EAC.Figure 3(A)
shovvs the cellular proliferative responses in vitro.
Proliferative response Of lymph node cells inllnunized
with Al(OH)3 eXhibited almOst the same extent as
thOse ilnlnunized wvith CFA or TルI,and it vvas higher
than that Of IFA―ilnmunized rats or that inllnunized
vvithout any attuVant. Compared to disease grading
(Fig. 2),we obServed a positive relationship between
proliferative responses and EAC scores.In contrast to
cellular illllnunity, antibody prOduction Of both lgG
and lgE did not cOrrelate vvith the disease grading
[Figs 3(B,C)].TherefOre the data show that EAC
deve10ped emciently in ratsimmunized with adiiVants
wvhich induce strong cellular inlrllunity.
巧セθtSげA′″ιiV`TttnψrげCιIIS οnιたθ IFlttθ
`lθ
nげ
DIs`αけ`r ChαIセnJ`げO1/A
To further investigate the role of celllllar irnmunity
in the efrector phase of EAC,vve conducted adoptive
transfer studies.Figure 4 sunllnarizes the inflltrated
cell numbers of recipient groups wvhich received OVA
prirned lymph nOde cells wvith or withOut activation in
vitro. In both grOups, the iniltrated cell number is
related tO the cell number which wvas adoptively
transferred.A comparison of the intensity of disease
betwveen recipients Of stilnulated cells and unstilnu―
lated cells showved that stimulation in vitro enhanced
dramatically the lymphocyte capacity to adoptively
transfer the disease vvhereas unstimulated cells had
Fllinillllla1 0r nO activity.
IIllmunitν lη RιθセIιntSげ07A Prir/1`dC`IIs
Our data suggest that cellular irnmunity is related to
the severity of disease in the induction phase. T0
fllrther analyse the roles of cellular inllnunity in the
effectoi phase, proliferation assays and ELISA vvere
performed with splenocytes and sera Of the recipient
rats,No proliferative responses were detected in most
recipient rats wvith the exception Of the group that
received 50×106 stimulated cells[Fig.5(A)].Low
levels Of lgC antibody production were found in lnost
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recipi nts[Fig.5(B)].The amplitude of Ab production
is dependent On the transferred cell number.IgE vvas
not detected in any recipients in our study(data nOt
shown).
A■αセSiSげR`ευlιntSげOIζA A4ιibθdi`s
To compare the inv01vement Of cellular inllnunity
vvith humoralillllmunity in the developllnent ofdisease,
pooled serum from OVA…immunized rats was il■iected
into naive recipient rats. The recipients vvere chal―
lenged and euthanized at various tilllle intervals.Even
though they developed edema in colliunctiVa and lid,
no cellular inlltration was observed(data nOt showvn).
4. I)iscusslon
C nerally speaking,allergic pathological conditions,
such as asthma,rhi itis or colliunCtiVitis are thought
o be dolninantly caused by lgE―Inediated humoral
iΠlrnunity as the initial step.Recently,several groups
suggested that cellular illlmunity rnay be the inducing
mechanism Of the allergic changes. For example,
A71artin's group shOvved that antigen speciac cD4+T―
cells could tran fer asthma in an experilnental anirnal
mo el(OhvenStein et al., 1993; Watanabe et al.,
1995).TheS stu es indicate that not only humOral
but alsO cellular ilnlnunity,especially T―cell―I llediated
illllnunity, is act vely involved in the induction and
effectOr phases of allergic reactions.
Although it is wvell knowvn that genetic factors are
irnportant in the induction of allergy,little is knOwn
concerning other elements vvhich inluence the in―
duction Of allergy.In experirnental rnodels,attuvants
are usual y used for effective induction of illlllllune
r sponses.It is also knOwn that some adiuVants tend
to induce cellular inllnunity, vvhile others enhance
humOral responses(Germann et al.,1995;Trinchieri,
1995;Mauri et al.,1996).If we COuld manipulate
illnrnune status towvard either cellular Or humoral by
anging a iuvantS, COmparison of adiuvants will
give us inforlnat on on wvhich inllllllunity is mainly
involved in the i duction of disease.These indings led
us to invest gate t e roles ofadiuvants in the inductiOn
of EAC.
The intensity of disease wvas compared using four
different adiuvantS. It is clear that adiuVants are
necessary for the inductiOn of disease(Fig。2).In our
system,ilnmunization was perforined rOutinely only
once. Yet, no disOasc Or illllmune response vvere
detected n rats immunized with OVA solution vvithout
any adiuvant iVe tilnes repeatedly(data nOt Shown).
Th se studies thus further indicate the essential role of
adiuVants in the development Of EAC.
予Ve also nOt d a d lf rence concerning the effective―
ness of disease inducti n among the four adiuvantS.
Rats illllllnuniZed vvith IFA demonstrated less severe
disease than thOse with CFA,TM or Al(OH)3(Fig.2).
It is of note that there seelns to be a relationship
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FIc.3.(A)Proliferativc rcsponse by LN cells of Lewis rats
immunizcd with OVA in four kinds Of adJuvants or without
any attuvant.Draining LN cells were harvcstcd and tested
for proliferation detailcd in materials and methods. Thc
rccordcd data are means of S I. valucs of tlA7o ratS of each
group Silnilar rcsults wvere obtained in four morc in―
dependent experiments.Thc combined mean cpnl values in
the unstimulatcd control cultures of rats of different
adJuvants were bctwccn 139 and 503.(■), WithOut
adiuVant;(◆),Al(OH)3;(▲)'CFA;(●),IFA;(▼),TM.(B)
Measurcmcnt of OVA siecinc lgG by ELISA in serum from
Lewis rats immunized with OVA in four kinds Of adJuvantS
or without any adJuvants.Serum was collected at thc time
0    50   100   150   200   250   300   350
!nf‖trated ce‖number
FIG.4.Iniltrated cell number in the collJunctival fornix of
recipicnts of OVA―primed cells either stimulated in vitro(+)
or not(―).Recipients were transferred with 2, 10 or
50×106 0vA prilned LN cells Four days later,they werc
challenged with OVA by cye drops and eyes,including the
lids, lvere harvested for histo10gy 24 hr aftcr challcngc.
χ―axis indicatcs the mean number of inlltrated cells of six
rats
between the grade of disease and cellular proliferative
responses in vitro in each group of attuvant[Fig.2,
3(A)],thuS Suggesting that cellular immunity is
donlinantly involved in the induction of disease in our
model. It is necessary to study cytokine production
both in vivo and in vitro to elucidate the exact
involvement of cellular inllnunity in the induction of
EAC.
Carreras et al.(1993)reported that activated T¨
cells,which are specinc to antigen and iniltrate the
COttunctiva, play an irnpOrtant role in the patho―
genesis of allergic coniunctiVitis.To clarif57 the role of
T―cells in the induction of EAC,we have employed the
system of adoptive transfer of activated T―cells into
naive recipients.WVe transferred lymph nOde cells from
ilnlnunized rats,either stilnulated in vitro or not,into
naive syngeneic recipients. Recipient rats demon―
strated cellular inlltration in the col■iunctiVa and lid
fo1lowing a challenge with OVA.The iniltrated cell
number vvas dependent on the transferred cell number
and stimulation in vitro ofthe illieCted cells.This is the
flrst report to showv that EAC is transferable by
illnrnune cells and cellular ilnmunity is actively
involved in the ettector phase Of development of this
disease.
In contrast to the emcient adoptive transfer of
of killing and assayc  for ELISA. χ―axis indicates dilution
factors of serunl,and υ―axis depi ts absorbancc at 610 nm.
Silnilar rcsults wcre obtained in four more independent
experiments.Symbol meaning arc samc as part(A).(C)
ルIeasurement of OVA specinc lgE by EIISA in serum fl・om
Lewis rats immunized with OVA in four kinds of attuvantS
or without any attuVant Dilution factor in this cxpcrimcnt
is ×40. χ～axis indicates absorbance at 610 nm. Sinlilar
results were obtaincd in four rnorc independent experiments.
(M),TM;(図,IFA;(N),CFA;(国),A(OH3;(■)'WithOut
adiuVan .
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them are exogenous antigens and, therefore, they
would be presented by rnaior hiStOCompatibility com¨
pleX(A/71HC)claSS II antigen leading to stimulation of
CD4 positive T―cells.
In conclusion, our studies suggest that cellular
ilnlnunity is essential botll in the induction and
e∬ectOr phases of EAC in Lewis rats using OVA as an
allergen,
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